Fortrea Holdings (FTRE) Cash & Current Investments (2022 - 2026)

Fortrea Holdings (FTRE) posted Cash & Current Investments of $147.5 million for Q1 2026, down 15.52% on a QoQ basis from $174.6 million in Q4 2025, and up 45.18% year-over-year from $101.6 million in Q1 2025.

Fortrea Holdings (FTRE) Cash & Current Investments (2022 - 2026) Analysis & Trends

Fortrea Holdings' Cash & Current Investments history runs 5 years deep, the most recent figure standing at $147.5 million for Q1 2026.

  • Quarterly Cash & Current Investments rose 45.18% year-over-year to $147.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $147.5 million (up 45.18% YoY) and the FY2025 annual result came in at $174.6 million, up 47.34% from the prior year.
  • Cash & Current Investments was $147.5 million for Q1 2026 at Fortrea Holdings, down from $174.6 million in the prior quarter.
  • Across five years, Cash & Current Investments topped out at $174.6 million in Q4 2025 and bottomed at $81.2 million in Q2 2025.
  • A 5-year average of $117.0 million and a median of $112.0 million in 2022 frame the typical range for Cash & Current Investments.
  • Peak annual rise in Cash & Current Investments reached 47.34% in 2025, while the deepest fall reached 35.66% in 2025.
  • Fortrea Holdings' Cash & Current Investments stood at $112.0 million in 2022, then declined by 3.04% to $108.6 million in 2023, then grew by 9.12% to $118.5 million in 2024, then soared by 47.34% to $174.6 million in 2025, then dropped by 15.52% to $147.5 million in 2026.
  • Business Quant data shows FTRE's Cash & Current Investments at $147.5 million in Q1 2026, $174.6 million in Q4 2025, and $131.3 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Oculis Holding AG 66,921.77 Bn 66,921.49 Bn - 283.54 Mn
2 Nanobiotix 1,911.83 Bn 1,911.77 Bn - 61.40 Mn
3 Akari Therapeutics 959.56 Bn 959.56 Bn - -
4 BeOne Medicines 471.57 Bn 466.77 Bn 1.35 Bn 4.79 Bn
5 Vertex Pharmaceuticals 122.01 Bn 114.76 Bn 2.59 Bn 7.25 Bn
6 Regeneron Pharmaceuticals 70.09 Bn 61.34 Bn 3.31 Bn 8.75 Bn
7 Belite Bio 62.68 Bn 62.68 Bn - -
8 Argenx Se 55.86 Bn 50.68 Bn 1.41 Bn 5.18 Bn
9 Alnylam Pharmaceuticals 37.48 Bn 34.47 Bn 959.66 Mn 3.01 Bn
10 Fortrea Holdings 1.81 Bn 1.67 Bn 123.60 Mn 147.50 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 147.50 Mn
Dec 31, 2025 174.60 Mn
Sep 30, 2025 131.30 Mn
Jun 30, 2025 81.20 Mn
Mar 31, 2025 101.60 Mn
Dec 31, 2024 118.50 Mn
Sep 30, 2024 105.30 Mn
Jun 30, 2024 126.20 Mn
Mar 31, 2024 92.80 Mn
Dec 31, 2023 108.60 Mn
Sep 30, 2023 107.50 Mn
Jun 30, 2023 114.30 Mn
Dec 31, 2022 112.00 Mn